A phase 1b study of isatuximab plus lenalidomide and dexamethasone for relapsed/refractory multiple myeloma
Martin, Thomas, Baz, Rachid, Benson, Don M., Lendvai, Nikoletta, Wolf, Jeffrey, Munster, Pamela, Lesokhin, Alexander M., Wack, Claudine, Charpentier, Eric, Campana, Frank, Vij, Ravi
Published in Blood (22.06.2017)
Published in Blood (22.06.2017)
Get full text
Journal Article
Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial
Stadtmauer, Edward A, Pasquini, Marcelo C, Blackwell, Beth, Hari, Parameswaran, Bashey, Asad, Devine, Steven, Efebera, Yvonne, Ganguly, Siddharta, Gasparetto, Cristina, Geller, Nancy, Horowitz, Mary M, Koreth, John, Knust, Kristin, Landau, Heather, Brunstein, Claudio, McCarthy, Philip, Nelson, Courtney, Qazilbash, Muzaffar H, Shah, Nina, Vesole, David H, Vij, Ravi, Vogl, Dan T, Giralt, Sergio, Somlo, George, Krishnan, Amrita
Published in Journal of clinical oncology (01.03.2019)
Published in Journal of clinical oncology (01.03.2019)
Get full text
Journal Article
CD56bright NK cells exhibit potent antitumor responses following IL-15 priming
Wagner, Julia A, Rosario, Maximillian, Romee, Rizwan, Berrien-Elliott, Melissa M, Schneider, Stephanie E, Leong, Jeffrey W, Sullivan, Ryan P, Jewell, Brea A, Becker-Hapak, Michelle, Schappe, Timothy, Abdel-Latif, Sara, Ireland, Aaron R, Jaishankar, Devika, King, Justin A, Vij, Ravi, Clement, Dennis, Goodridge, Jodie, Malmberg, Karl-Johan, Wong, Hing C, Fehniger, Todd A
Published in The Journal of clinical investigation (01.11.2017)
Published in The Journal of clinical investigation (01.11.2017)
Get full text
Journal Article
Phase 1b trial of pembrolizumab monotherapy for relapsed/refractory multiple myeloma: KEYNOTE‐013
Ribrag, Vincent, Avigan, David E., Green, Damian J., Wise‐Draper, Trisha, Posada, Juan G., Vij, Ravi, Zhu, Ying, Farooqui, Mohammed Z. H., Marinello, Patricia, Siegel, David S.
Published in British journal of haematology (01.08.2019)
Published in British journal of haematology (01.08.2019)
Get full text
Journal Article
3D tissue-engineered bone marrow as a novel model to study pathophysiology and drug resistance in multiple myeloma
de la Puente, Pilar, Muz, Barbara, Gilson, Rebecca C, Azab, Feda, Luderer, Micah, King, Justin, Achilefu, Samuel, Vij, Ravi, Azab, Abdel Kareem
Published in Biomaterials (01.12.2015)
Published in Biomaterials (01.12.2015)
Get full text
Journal Article
Integrated safety profile of single-agent carfilzomib: experience from 526 patients enrolled in 4 phase II clinical studies
Siegel, David, Martin, Thomas, Nooka, Ajay, Harvey, R Donald, Vij, Ravi, Niesvizky, Ruben, Badros, Ashraf Z, Jagannath, Sundar, McCulloch, Leanne, Rajangam, Kanya, Lonial, Sagar
Published in Haematologica (Roma) (01.11.2013)
Published in Haematologica (Roma) (01.11.2013)
Get full text
Journal Article
Elotuzumab in Combination With Lenalidomide and Low-Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma
LONIAL, Sagar, VIJ, Ravi, SINGHAL, Anil K, JAGANNATH, Sundar, HAROUSSEAU, Jean-Luc, FACON, Thierry, MOREAU, Philippe, MAZUMDER, Amitabha, KAUFMAN, Jonathan L, LELEU, Xavier, CLAIRE TSAO, L, WESTLAND, Christopher
Published in Journal of clinical oncology (01.06.2012)
Published in Journal of clinical oncology (01.06.2012)
Get full text
Journal Article
Measuring cardiopulmonary complications of carfilzomib treatment and associated risk factors using the SEER‐Medicare database
Fakhri, Bita, Fiala, Mark A., Shah, Nina, Vij, Ravi, Wildes, Tanya M.
Published in Cancer (15.02.2020)
Published in Cancer (15.02.2020)
Get full text
Journal Article
Co-evolution of tumor and immune cells during progression of multiple myeloma
Liu, Ruiyang, Gao, Qingsong, Foltz, Steven M., Fowles, Jared S., Yao, Lijun, Wang, Julia Tianjiao, Cao, Song, Sun, Hua, Wendl, Michael C., Sethuraman, Sunantha, Weerasinghe, Amila, Rettig, Michael P., Storrs, Erik P., Yoon, Christopher J., Wyczalkowski, Matthew A., McMichael, Joshua F., Kohnen, Daniel R., King, Justin, Goldsmith, Scott R., O’Neal, Julie, Fulton, Robert S., Fronick, Catrina C., Ley, Timothy J., Jayasinghe, Reyka G., Fiala, Mark A., Oh, Stephen T., DiPersio, John F., Vij, Ravi, Ding, Li
Published in Nature communications (07.05.2021)
Published in Nature communications (07.05.2021)
Get full text
Journal Article
SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution
Miller, Christopher A, White, Brian S, Dees, Nathan D, Griffith, Malachi, Welch, John S, Griffith, Obi L, Vij, Ravi, Tomasson, Michael H, Graubert, Timothy A, Walter, Matthew J, Ellis, Matthew J, Schierding, William, DiPersio, John F, Ley, Timothy J, Mardis, Elaine R, Wilson, Richard K, Ding, Li
Published in PLoS computational biology (01.08.2014)
Published in PLoS computational biology (01.08.2014)
Get full text
Journal Article
Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potential
Wong, Terrence N., Miller, Christopher A., Jotte, Matthew R. M., Bagegni, Nusayba, Baty, Jack D., Schmidt, Amy P., Cashen, Amanda F., Duncavage, Eric J., Helton, Nichole M., Fiala, Mark, Fulton, Robert S., Heath, Sharon E., Janke, Megan, Luber, Kierstin, Westervelt, Peter, Vij, Ravi, DiPersio, John F., Welch, John S., Graubert, Timothy A., Walter, Matthew J., Ley, Timothy J., Link, Daniel C.
Published in Nature communications (31.01.2018)
Published in Nature communications (31.01.2018)
Get full text
Journal Article
Tumor microenvironment-targeted nanoparticles loaded with bortezomib and ROCK inhibitor improve efficacy in multiple myeloma
Federico, Cinzia, Alhallak, Kinan, Sun, Jennifer, Duncan, Kathleen, Azab, Feda, Sudlow, Gail P., de la Puente, Pilar, Muz, Barbara, Kapoor, Vaishali, Zhang, Luna, Yuan, Fangzheng, Markovic, Matea, Kotsybar, Joseph, Wasden, Katherine, Guenthner, Nicole, Gurley, Shannon, King, Justin, Kohnen, Daniel, Salama, Noha N., Thotala, Dinesh, Hallahan, Dennis E., Vij, Ravi, DiPersio, John F., Achilefu, Samuel, Azab, Abdel Kareem
Published in Nature communications (27.11.2020)
Published in Nature communications (27.11.2020)
Get full text
Journal Article
Evolution and structure of clinically relevant gene fusions in multiple myeloma
Foltz, Steven M., Gao, Qingsong, Yoon, Christopher J., Sun, Hua, Yao, Lijun, Li, Yize, Jayasinghe, Reyka G., Cao, Song, King, Justin, Kohnen, Daniel R., Fiala, Mark A., Ding, Li, Vij, Ravi
Published in Nature communications (29.05.2020)
Published in Nature communications (29.05.2020)
Get full text
Journal Article
A dose-finding Phase 2 study of single agent isatuximab (anti-CD38 mAb) in relapsed/refractory multiple myeloma
Mikhael, Joseph, Richter, Joshua, Vij, Ravi, Cole, Craig, Zonder, Jeffrey, Kaufman, Jonathan L., Bensinger, William, Dimopoulos, Meletios, Lendvai, Nikoletta, Hari, Parameswaran, Ocio, Enrique M., Gasparetto, Cristina, Kumar, Shaji, Oprea, Corina, Chiron, Marielle, Brillac, Claire, Charpentier, Eric, San-Miguel, Jesús, Martin, Thomas
Published in Leukemia (01.12.2020)
Published in Leukemia (01.12.2020)
Get full text
Journal Article
Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction
Devine, Steven M., Vij, Ravi, Rettig, Michael, Todt, Laura, McGlauchlen, Kiley, Fisher, Nicholas, Devine, Hollie, Link, Daniel C., Calandra, Gary, Bridger, Gary, Westervelt, Peter, DiPersio, John F.
Published in Blood (15.08.2008)
Published in Blood (15.08.2008)
Get full text
Journal Article
Belantamab mafodotin monotherapy for relapsed or refractory multiple myeloma: a real-world observational study in the United States
Hultcrantz, Malin, Kleinman, David, Vij, Ravi, Escalante, Fernando, Delforge, Michel, Kotowsky, Nirali, Bitetti, Jacopo, Boytsov, Natalie, Camadoo-O'Byrne, Leena, Happ, Lindsey Powers, Germain, Guillaume, Urosevic, Ana, Mahendran, Malena, Duh, Mei Sheng, Laliberte, Francois, Cavo, Michele, Lee, Hans C
Published in Haematologica (Roma) (17.10.2024)
Published in Haematologica (Roma) (17.10.2024)
Get full text
Journal Article
VLA4-Targeted Nanoparticles Hijack Cell Adhesion-Mediated Drug Resistance to Target Refractory Myeloma Cells and Prolong Survival
Fontana, Francesca, Scott, Michael J, Allen, John S, Yang, Xiaoxia, Cui, Grace, Pan, Dipanjan, Yanaba, Noriko, Fiala, Mark A, O'Neal, Julie, Schmieder-Atteberry, Anne H, Ritchey, Julie, Rettig, Michael, Simons, Kathleen, Fletcher, Steven, Vij, Ravi, DiPersio, John F, Lanza, Gregory M
Published in Clinical cancer research (01.04.2021)
Published in Clinical cancer research (01.04.2021)
Get full text
Journal Article
Proteasome inhibitor associated thrombotic microangiopathy
Yui, Jennifer C., Van Keer, Jan, Weiss, Brendan M., Waxman, Adam J., Palmer, Matthew B., D'Agati, Vivette D., Kastritis, Efstathios, Dimopoulos, Meletios A., Vij, Ravi, Bansal, Dhruv, Dingli, David, Nasr, Samih H., Leung, Nelson
Published in American journal of hematology (01.09.2016)
Published in American journal of hematology (01.09.2016)
Get full text
Journal Article
A phase 2 study of isatuximab monotherapy in patients with multiple myeloma who are refractory to daratumumab
Mikhael, Joseph, Belhadj-Merzoug, Karim, Hulin, Cyrille, Vincent, Laure, Moreau, Philippe, Gasparetto, Cristina, Pour, Ludek, Spicka, Ivan, Vij, Ravi, Zonder, Jeffrey, Atanackovic, Djordje, Gabrail, Nashat, Martin, Thomas G., Perrot, Aurore, Bensfia, Samira, Weng, Qilong, Brillac, Claire, Semiond, Dorothée, Macé, Sandrine, Corzo, Kathryn P., Leleu, Xavier
Published in Blood cancer journal (New York) (12.05.2021)
Published in Blood cancer journal (New York) (12.05.2021)
Get full text
Journal Article